AstraZeneca reported encouraging top-line results from the Phase III BaxHTN trial, demonstrating baxdrostat's statistically significant and clinically significant decrease in mean seated systolic blood pressure
Baxdrostat at two doses (2 mg and 1 mg) showed a statistically significant and clinically relevant reduction in mean sitting systolic blood pressure (SBP) at 12 weeks when compared with placebo, according to positive high-level data from the BaxHTN
The World Health Organization (WHO) has taken a significant step forward by endorsing Gilead's lenacapavir, an injectable drug twice-yearly, as a preventive measure to protect against HIV. The WHO confirmed this recommendation on Monday morning...
Aayush Wellness, a leading player in the Ayurvedic and wellness segments, has announced a strategic expansion of its nutraceutical product lines in order to bolster its presence into India's robust and emerging health and wellness sector...
Sun Pharmaceutical Industries Ltd. has announced the availability of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S. to treat severe alopecia areata, a severe autoimmune disorder that unpredictably causes hair loss in adult patients.
In a substantial move for India's pharmaceutical manufacturing sector, Sun Pharmaceutical Industries has committed to an investment of Rs 3,800 crore in Madhya Pradesh, creating an estimated 2,000 new jobs...
In a significant advancement for artificial intelligence technology's application to public health, Rajasthan's MadhuNetr DR-AI programme, which uses AI to assist screening for diabetic retinopathy, has received approval by the government for...
In a significant move towards the evolution of military healthcare logistics, the Armed Forces Medical Services (AFMS) is investigating the feasibility of using drones for transportation of blood bags, medicines and emergency supplies, to remote...
.jpg)
Pharma major Cipla is preparing to enter India's weight management space as a part of its strategy to leverage emerging healthcare opportunities and niche therapy opportunities.
In an ambitious step to transform India's healthcare system, the Adani Group announced that they are developing two AI-first Health Cities in Ahmedabad and Mumbai, with an initial investment of ?6,000 crore. The Cities will integrate healthcare...
.jpg)
.jpg)
, CDSCO.jpg)